Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
 & Establishment (Fertility Clinics, Hospitals, Research Banks) - EconoTimes)
Dublin, Dec. 19, 2017 -- The "Global Infertility Treatment Market Analysis By Procedure (ART, Artificial Insemination, Fertility Surgery, Fertility Drugs, Others), Establishment (Fertility Clinics, Hospitals, Research Banks), By Region, By Country (2012-2022)" report has been added to Research and Markets' offering.
The global market is projected to display a robust growth represented by a CAGR of 8.25% during 2017-2022, chiefly driven by favourable government reforms as well as introduction of new techniques of IVF.
Over the recent years, the global infertility treatment has been growing rapidly on account of rising awareness of infertility treatment through government awareness campaign, rising demand of IVF treatment worldwide and surge in medical tourism.
Among the regions, Europe is predicted to advance at the highest rate, mainly driven by high acceptance of new techniques, rising medical tourism in UK and favourable insurance policies.
Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
- Infertility Treatment Market
- Infertility Treatment Procedure - ART or Assisted Reproductive Technique, Artificial Insemination, Fertility Surgery, Fertility Drugs, Other Procedures
- By ART Type - IVF, ICSI, Other Procedure
- Analysis By Patient Type - Male and Female
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Infertility Treatment Market Outlook
5. Global Infertility Treatment Market: Growth and Forecast
6. Global Infertility Treatment Market - Analysis By Procedure
7. Global Infertility Treatment Market- By ART Procedure
8. Global Infertility Treatment Market- By Patient Type
9. Global Infertility Treatment Market - By Establishment
10. Global Infertility Treatment Market - Regional Analysis
11. Global Infertility Treatment Market Dynamics
12. Market Trends
13. Porter's Five Force Analysis
14. SWOT Analysis
15. Policy and Regulations
16. Company Profiles
- CCRM
- Ferring Pharmaceutical
- Merck & Co
- Monash IVF Group
- The Cooper Company
- Thermo Fisher
- United Healthcare Group
For more information about this report visit https://www.researchandmarkets.com/research/twwbtl/global?w=12
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health, Sexual and Reproductive Health Drugs
